45
DalCor Pharmaceuticals US, LLC raises $7M under Reg D
Company raise · Closed · SARASOTA, FL · Form D filed 2026-08-28
First raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Douglas Michael Dixon | Director |
| Paul Michael Fonteyne | Director |
Signed by Douglas Michael Dixon, Manager.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.